Oncology Nurse Advisor (10/21, Garlapow) reports, “Aerobic physical activity (APA) modestly reduced depressive symptoms in adults with cancer, with significant effects observed within 1 month of intervention and 6 to 12 months postintervention, according to results from a systematic review and meta-analysis.” The “study encompassed 25 randomized clinical trials with 1931 participants aged 18 to 80 years and showed a significant reduction in self-reported depression scores following APA interventions.” The findings were published in JAMA Network Open.

Related Links:

— “Physical Activity Reduced Long-Term Depression in Patients With Cancer,” Megan Garlapow, PhD, Oncology Nurse Advisor, October 21, 2024

HealthDay (10/18, Thompson ) reported, “Depression can make it tougher for athletes to recover from a concussion, and vice versa, a new study finds.” Researchers found that “student athletes who have both concussion and depression have significantly worse symptoms for both conditions.” Study results indicate that “electrical signals in the brain are more disrupted among people with both concussion and depression than among those with only one of these conditions.” The findings were published in Brain Research.

Related Links:

— “Sports Concussion Outcomes Can Be Made Worse By Depression,” Dennis Thompson, HealthDay, October 18, 2024

Psychiatric News (10/18) reported, “An estimated 15.5 million adults in the United States – roughly 1 in 16 – have been diagnosed with attention deficit/hyperact ivity disorder (ADHD), according to a survey analysis.” The research “also found that nearly half of adults with ADHD reported using telehealth and that most who take stimulant medications for their ADHD have had problems filling their prescriptions over the past year.” The findings were published in the Morbidity and Mortality Weekly Report.

Related Links:

— “1 in 16 US Adults Has ADHD, Nearly Half With ADHD Use Telemedicine,” Psychiatric News, October 18, 2024

ABC News (10/17, Shareef) reports, “A new study suggests that GLP-1 agonist medications like Ozempic [semaglutide], which are used for diabetes management and weight loss, may help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.” The study “analyzed the health records of 1.3 million people from 136 U.S. hospitals for nearly nine years,” including “the records of 500,000 people with opioid use and more than 800,000 with alcohol use disorder.” Researchers found that “those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn’t take the medication.” The findings were published in Addiction.

Healio (10/17, Viguers ) reports one researcher said “this broader therapeutic application could help reduce cravings and the risk of severe outcomes, including overdose and intoxication, which are critical issues in” the management of substance use disorders.

Also reporting is CBS News (10/17, Moniuszko ).

Related Links:

— “Weight loss drugs like Ozempic may help reduce overdose risks: Study,” Dr. Faizah Shareef, ABC News, October 17, 2024

ABC News (10/17, Livingston) reports that on Thursday, “the Federal Communications Commission unanimously voted…to approve new rules requiring all wireless carriers to implement georouting for calls to the 988 Suicide &Crisis Lifeline in a move it says will help ‘save more lives.’”

When an individual “calls 988, that call is routed to one of the Lifeline’s 200-plus crisis centers around the” US. These “new rules will require carriers to route calls based on where the call was placed, allowing for a more localized response.”

Related Links:

— “FCC approves georouting for 988 Suicide & Crisis Lifeline, clearing the way for more localized care,” Kelly Livingston, ABC News, October 17, 2024